...
首页> 外文期刊>BMC Pulmonary Medicine >Clinical features and prognostic analysis of patients with Aspergillus isolation during acute exacerbation of chronic obstructive pulmonary disease
【24h】

Clinical features and prognostic analysis of patients with Aspergillus isolation during acute exacerbation of chronic obstructive pulmonary disease

机译:慢性阻塞性肺疾病急性加剧期间曲霉患者患者的临床特征及预后分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Lower respiratory tract (LRT) specimen culture is widely performed for the identification of Aspergillus. We investigated the clinical features and prognosis of patients with Aspergillus isolation from LRT specimens during acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This is a 6-year single-center, real-world study. 75 cases out of 1131 hospitalized AECOPD patients were positive for Aspergillus. These patients were carefully evaluated and finally diagnosed of pulmonary aspergillosis (PA, 60 cases, 80%) or colonization (15 cases, 20%). Comparisons of clinical data were performed between these two groups. A cox regression model was used to confirm prognostic factors of Aspergillus infection. The PA group had worse lung function and higher rates of systemic corticosteroid use and broad-spectrum antibiotic use before admission than the colonization group. The PA group had significantly higher in-hospital mortality and 180-day mortality than the colonization group (45% (27/60) vs. 0% (0/15), p?=?0.001, and 52.5% (31/59) vs. 6.7% (1/15), p 700?mg (HR 2.452, 95% CI 1.134–5.300, p?=?0.023) and respiratory failure at admission (HR 5.983, 95% CI 2.487–14.397, p??0.001) were independently associated with increased mortality. Significant survival differential was observed among PA patients without antifungals and antifungals initiated before and after Aspergillus positive culture (p?=?0.001). Aspergillus isolation in hospitalized AECOPD patients largely indicated PA. AECOPD patients with PA had worse prognosis than those with Aspergillus colonization. Empirical antifungal therapy is warranted to improve the prognosis for Aspergillus infection.
机译:较低呼吸道(LRT)样本培养物被广泛进行用于鉴定曲霉菌。我们调查了慢性阻塞性肺病(AECOPD)急性加剧期间从LRT标本中患有LRT标本的患者的临床特征和预后。这是一个6年的单中心,真实的研究。 1131名住院病患者的75例患者为曲霉阳性。这些患者经过精心评估,最终诊断为肺动脉杆菌(PA,60例,80%)或定植(15例,20%)。在这两组之间进行临床数据的比较。 COX回归模型用于确认曲霉感染的预后因素。 PA组肺功能越差,较高的全身皮质类固醇使用率和频谱抗生素使用前的广谱抗生素比定植组。 PA组的医院死亡率显着高,比殖民化组约180日死亡率(45%(27/60)与0%(0/15),P?= 0.001,52.5%(31/59) )与6.7%(1/15),P 700?Mg(HR 2.452,95%CI 1.134-5.300,P?= 0.023)和入院呼吸衰竭(HR 5.983,95%CI 2.487-14.397,P? & 0.001)与增加的死亡率不同。在没有抗真菌和患者阳性培养之前和之后发起的PA患者的PA患者中观察到显着存活差异(P?= 0.001)。住院治疗的患者在很大程度上表明PA。AECOPD PA患者的预后比患有曲霉殖民化的患者更差。经验抗真菌治疗得到了改善曲霉感染的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号